Hypersensitivity to the active substance or to any of the excipients listed in 'Description'.
Patients with aphakic eyes or intraocular lens (IOL) inserted eyes (see 'Adverse Reactions').
Concomitant use with tafluprost (see 'Interactions').
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.